Literature DB >> 10813232

Epidemiology of lung cancer.

K E Osann1.   

Abstract

Lung cancer incidence is now decreasing in US men. Although rates continue to increase in women, the rate of increase is declining. Most lung cancer in men and women is attributable to cigarette smoking. Histologic patterns are consistent with smoking trends for gender, race, and age. Trends in adenocarcinoma may be related to an increase in exposure to tobacco-specific nitrosamines from low-tar cigarettes. Other risk factors, including exposure to residential radon, occupational exposures, diet, and family history, have been shown to increase risk of lung cancer independent of cigarette smoking. Recent research in molecular epidemiology has greatly increased our understanding of the mechanism of lung carcinogenesis and the interactions between exposure to lung carcinogens (smoking, occupational exposures, radon), diet, and heritable variations in susceptibility.

Entities:  

Mesh:

Year:  1998        PMID: 10813232     DOI: 10.1097/00063198-199807000-00002

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  12 in total

Review 1.  The lung cancer paradox: time for action.

Authors:  R C Rintoul; T Sethi
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 2.  CYP1A1 MspI polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.

Authors:  Xin Wang; Kai Yue; Li-Ran Hao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer.

Authors:  M Lees; M Aristides; N Maniadakis; J McKendrick; N Botwood; D Stephenson
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism.

Authors:  Akiko Kikuchi; Mutsuo Yamaya; Satoshi Suzuki; Hiroyasu Yasuda; Hiroshi Kubo; Katsutoshi Nakayama; Masashi Handa; Takahiko Sasaki; Shigeki Shibahara; Kiyohisa Sekizawa; Hidetada Sasaki
Journal:  Hum Genet       Date:  2005-02-02       Impact factor: 4.132

5.  Cancer incidence among Danish seafarers: a population based cohort study.

Authors:  L Kaerlev; J Hansen; H L Hansen; P S Nielsen
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

6.  The synergistic induction of cyclooxygenase-2 in lung fibroblasts by angiotensin II and pro-inflammatory cytokines.

Authors:  Takaya Matsuzuka; Kathryn Miller; Lara Pickel; Chiyo Doi; Rie Ayuzawa; Masaaki Tamura
Journal:  Mol Cell Biochem       Date:  2008-10-01       Impact factor: 3.396

7.  Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study.

Authors:  Jessie A Satia; Alyson Littman; Christopher G Slatore; Joseph A Galanko; Emily White
Journal:  Am J Epidemiol       Date:  2009-02-10       Impact factor: 4.897

8.  Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre.

Authors:  B S Al-Alao; D S O'Callaghan; K Gately; S Nicholson; L E Coate; F O'Connell; E McGovern; K J O'Byrne; V K Young
Journal:  Ir J Med Sci       Date:  2012-11-09       Impact factor: 1.568

9.  Mutagenesis and repair by low doses of alpha radiation in mammalian cells.

Authors:  Theodore T Puck; Robert Johnson; Patricia Webb; Helen Cui; Joseph G Valdez; Harry Crissman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-27       Impact factor: 11.205

10.  Cytochrome P450 1A1 exon 7 polymorphism and susceptibility to lung cancer in the Chinese population: an updated meta-analysis and review.

Authors:  Xiu-Ping Wei; Jie Hu
Journal:  Onco Targets Ther       Date:  2015-07-02       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.